Hirotsugu Uemura


Ontology type: schema:Person     


Person Info

NAME

Hirotsugu

SURNAME

Uemura

Publications in SciGraph latest 50 shown

  • 2022-04-20 Real-world safety and effectiveness of nivolumab for advanced renal cell carcinoma in Japan: a post-marketing surveillance in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2022-01-01 Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-11-20 Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-11-20 Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer in BRITISH JOURNAL OF CANCER
  • 2021-08-27 Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-07-21 Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2021-06-23 T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2021-03-01 A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer in WORLD JOURNAL OF UROLOGY
  • 2021-02-11 Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2020-11-23 Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2020-10-22 Correction to: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study in BMC UROLOGY
  • 2020-09-02 Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study in BMC UROLOGY
  • 2020-06-09 A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2020-03-07 Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer in HUMAN CELL
  • 2020-02-05 Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2019-12-10 A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2019-06-19 Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2019-03-14 Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2019-01-07 Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study in BMC CANCER
  • 2018-05-22 Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2018-05-12 Prediction of Optimal Number of Cycles in Docetaxel Regimen for Patients with mCRPC in HORMONE THERAPY AND CASTRATION RESISTANCE OF PROSTATE CANCER
  • 2018-05-12 Chemotherapy with Cabazitaxel for mCRPC in Japanese Men in HORMONE THERAPY AND CASTRATION RESISTANCE OF PROSTATE CANCER
  • 2018-02-08 Immune Therapy for Castration-Resistant Prostate Cancer in HORMONE THERAPY AND CASTRATION RESISTANCE OF PROSTATE CANCER
  • 2017-08-02 Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2017-05-31 Personalized peptide vaccines and their relation to other therapies in urological cancer in NATURE REVIEWS UROLOGY
  • 2017-05-06 Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2016-01-21 A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2015-12-22 Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2015-05-17 Involvement of renin–angiotensin–aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury in WORLD JOURNAL OF UROLOGY
  • 2015-05-08 Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2014-10-30 Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis in WORLD JOURNAL OF UROLOGY
  • 2014-10-25 Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2014-09-17 Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system in MOLECULAR CANCER
  • 2014-09-16 Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study in WORLD JOURNAL OF UROLOGY
  • 2014-09 Cutaneous angiosarcoma at an interval of thirty-six years from radiation for a testicular germ cell tumor in EUROPEAN JOURNAL OF DERMATOLOGY
  • 2014-03-12 Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition in UROLITHIASIS
  • 2014-01-17 Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study in WORLD JOURNAL OF UROLOGY
  • 2013-11-23 Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2013-08-03 Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2010-02-10 A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2009-05-16 Chronic treatment with a PDE5 inhibitor increases contractile force of normal bladder in rats in INTERNATIONAL UROLOGY AND NEPHROLOGY
  • 2008-03-12 Tumor vaccines in renal cell carcinoma in WORLD JOURNAL OF UROLOGY
  • 2006-11-18 Bladder leiomyosarcoma in a boy in INTERNATIONAL UROLOGY AND NEPHROLOGY
  • 2006-08-26 Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2006-06 A malignant Leydig cell tumor of the testis in INTERNATIONAL UROLOGY AND NEPHROLOGY
  • 2001-08-14 Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma in BRITISH JOURNAL OF CANCER
  • 1999-09-24 MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas in BRITISH JOURNAL OF CANCER
  • 1999-03-12 E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion in BRITISH JOURNAL OF CANCER
  • 1997-09 A histopathological mapping study of the urinary bladder tumors induced byN-butyl-N-(4-hydroxybutyl)nitrosamine in dogs in UROLITHIASIS
  • 1994 Tools for Vaccination and Immunotherapy: Internal-Image Anti-idiotype Antibodies Resembling the Renal Cell Carcinoma Associated Antigen G250 in CONTEMPORARY RESEARCH ON RENAL CELL CARCINOMA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.258622.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413045.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.261356.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419953.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.444883.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.174567.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.263171.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410814.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412541.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.136593.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.440917.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410781.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15276.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.268397.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267335.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.177174.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413376.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410818.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.461877.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410783.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413111.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412857.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.261445.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Uemura", 
        "givenName": "Hirotsugu", 
        "id": "sg:person.01051464055.75", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-3665-9523"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051464055.75", 
          "https://orcid.org/0000-0002-3665-9523"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-05-10T11:29", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/person/person_720.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01051464055.75'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01051464055.75'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01051464055.75'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01051464055.75'


     

    This table displays all metadata directly associated to this object as RDF triples.

    67 TRIPLES      11 PREDICATES      36 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01051464055.75 schema:affiliation Necff4e9273894fd0b09d797a87744746
    2 grid-institutes:grid.10417.33
    3 grid-institutes:grid.136593.b
    4 grid-institutes:grid.15276.37
    5 grid-institutes:grid.174567.6
    6 grid-institutes:grid.177174.3
    7 grid-institutes:grid.261356.5
    8 grid-institutes:grid.261445.0
    9 grid-institutes:grid.263171.0
    10 grid-institutes:grid.267335.6
    11 grid-institutes:grid.268397.1
    12 grid-institutes:grid.410781.b
    13 grid-institutes:grid.410783.9
    14 grid-institutes:grid.410814.8
    15 grid-institutes:grid.410818.4
    16 grid-institutes:grid.412541.7
    17 grid-institutes:grid.412857.d
    18 grid-institutes:grid.413045.7
    19 grid-institutes:grid.413111.7
    20 grid-institutes:grid.413376.4
    21 grid-institutes:grid.419953.3
    22 grid-institutes:grid.440917.f
    23 grid-institutes:grid.444883.7
    24 grid-institutes:grid.461877.b
    25 schema:familyName Uemura
    26 schema:givenName Hirotsugu
    27 schema:identifier N117f95918b9d4b6d9ce3bc3b501b5aec
    28 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051464055.75
    29 https://orcid.org/0000-0002-3665-9523
    30 schema:sdDatePublished 2022-05-10T11:29
    31 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    32 schema:sdPublisher Na1735626b84f4275a1e79ea3040e92b3
    33 sgo:license sg:explorer/license/
    34 sgo:sdDataset persons
    35 rdf:type schema:Person
    36 N117f95918b9d4b6d9ce3bc3b501b5aec schema:name orcid_id
    37 schema:value 0000-0002-3665-9523
    38 rdf:type schema:PropertyValue
    39 Na1735626b84f4275a1e79ea3040e92b3 schema:name Springer Nature - SN SciGraph project
    40 rdf:type schema:Organization
    41 Necff4e9273894fd0b09d797a87744746 schema:affiliation grid-institutes:grid.258622.9
    42 sgo:isCurrent true
    43 rdf:type schema:OrganizationRole
    44 grid-institutes:grid.10417.33 schema:Organization
    45 grid-institutes:grid.136593.b schema:Organization
    46 grid-institutes:grid.15276.37 schema:Organization
    47 grid-institutes:grid.174567.6 schema:Organization
    48 grid-institutes:grid.177174.3 schema:Organization
    49 grid-institutes:grid.258622.9 schema:Organization
    50 grid-institutes:grid.261356.5 schema:Organization
    51 grid-institutes:grid.261445.0 schema:Organization
    52 grid-institutes:grid.263171.0 schema:Organization
    53 grid-institutes:grid.267335.6 schema:Organization
    54 grid-institutes:grid.268397.1 schema:Organization
    55 grid-institutes:grid.410781.b schema:Organization
    56 grid-institutes:grid.410783.9 schema:Organization
    57 grid-institutes:grid.410814.8 schema:Organization
    58 grid-institutes:grid.410818.4 schema:Organization
    59 grid-institutes:grid.412541.7 schema:Organization
    60 grid-institutes:grid.412857.d schema:Organization
    61 grid-institutes:grid.413045.7 schema:Organization
    62 grid-institutes:grid.413111.7 schema:Organization
    63 grid-institutes:grid.413376.4 schema:Organization
    64 grid-institutes:grid.419953.3 schema:Organization
    65 grid-institutes:grid.440917.f schema:Organization
    66 grid-institutes:grid.444883.7 schema:Organization
    67 grid-institutes:grid.461877.b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...